It was found that in batches 2127580 and 2132779 the level of the impurity N-nitroso fluoxetine exceeds the temporary limit acceptable to EMA, which means loss of the required quality of the medicine and a potential risk to human health. Potential effects: possible carcinogenic effects with long-term use, impaired treatment efficacy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ
Related